Gossamer Bio (NASDAQ:GOSS) Receives “Buy” Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $10.00 target price on the stock. HC Wainwright also issued estimates for Gossamer Bio’s FY2028 earnings at $0.30 EPS. Separately, Wedbush reaffirmed an outperform rating and […]
More Stories
Who is Jonathan Joly? Age, Marriage, and Net Worth in 2026
If you like to scroll on social media, the chances of you witnessing Jonathan Joly are high. Are you also...
Rory McIlroy Wins Back-to-Back Masters Titles to Join Jack Nicklaus, Nick Faldo, and Tiger Woods
By The Associated Press AUGUSTA, Ga.—Rory McIlroy joined more elite company Sunday at the Masters when he pulled away with...
At Least 30 Dead in Stampede at Haiti’s Historic Laferriere Citadel
By Reuters At least 30 people were killed on Saturday in a stampede in the northern countryside of Haiti, authorities...
Oil Prices Rise After US Announces Blockade on Iranian Ports
By Naveen Athrappully Brent crude oil futures prices surged late Sunday following the United States threatening to block Iranian ports...
Eric Swalwell Ends Bid for California Governor Amid Sexual Misconduct Allegations
By Joseph Lord Rep. Eric Swalwell (D-Calif.) suspended his bid for California governor on Sunday after reports emerged accusing the...
Judge Orders Month-Long Pause on Process for Alberta Separation Referendum Petition
By Olivia Gomm An Alberta judge has granted a one-month stay on the validation process of a petition to trigger...